En

Council

The Council consists of the members of the EC and one delegate of each Adhering Organisation.

According to the new statutes, the voting rights are allotted according to the following rules:

  • members of the EC: 1 vote,
  • countries with up to 99 members: 2 votes,
  • countries with 100-199 members: 3 votes,
  • countries with 200-399 members: 4 votes,
  • countries with 400-599 members: 5 votes,
  • countries with 600-899 members: 6votes,
  • countries with more than 899 members: 7 votes.

As for countries with more than one Adhering Organisation, votes will be proportionally distributed among them, taking into account their respective memberships. The resulting number will be rounded off to the closest digit.

David Alker Associates, United Kingdom
The Biological and Medicinal Chemistry Sector (BMCS) of the Royal Society of Chemistry (RSC)

Novartis, Switzerland
EFMC Executive Committee

Institute of Physiologically Active Compounds, Russia
The D.I. Mendeleev Russian Chemical Society, Medicinal Chemistry Section

Hacettepe University, Turkey
Turkish Association of Medicinal and Pharmaceutical Chemistry

University of Copenhagen, Denmark
The Danish Society for Medicinal Chemistry and Chemical Biology

Universität Kiel, Germany
German Pharmaceutical Society, Section of Pharmaceutical/Medicinal Chemistry

VU University Amsterdam, The Netherlands
Division Medicinal Chemistry & Chemical Biology, Royal Netherlands Chemical Society (KNCV-MCCB)

Universidad San Pablo Ceu, Spain
Sociedad Española de Química Terapéutica

Charles University, Czech Republic
Section of Synthetic Drug of the Czech Pharmaceutical Society

Latvian Institute of Organic Synthesis, Latvia
Latvian Association for Medicinal Chemistry

Croatian Chemical Society, Croatia
Croatian Chemical Society, Section of Medicinal/Pharmaceutical Chemistry

Helmholtz INstitute for Pharmaceutical Research Saarland, Germany
Division of Medicinal Chemistry of the German Chemical Society (GDCh)

F. Hoffmann-La Roche Ltd., Switzerland
Division for Medicinal Chemistry & Chemical Biology (DMCCB)

Karolinska Institutet, Sweden
Swedish Pharmaceutical Society

Uppsala University, Sweden
EFMC Executive Committee

Hungarian Academy of Sciences, Hungary
Organic and Medicinal Chemistry Division (OMCD) of the Hungarian Chemical Society (HCS)

Jagiellonian University, Poland
Polish Society of Medicinal Chemistry

University of Ljubljana, Slovenia
Section for Medicinal Chemistry of the Slovenian Pharmaceutical Society

University of Vienna, Austria
Austrian Chemical Society, Medicinal Chemistry Section

France
Société de Chimie Thérapeutique

University of Lisbon, Portugal
Division of Medicinal Chemistry of the Portuguese Chemical Society

University of Athens, Greece
Hellenic Society of Medicinal Chemistry

University of Lisbon, Portugal
EFMC Executive Committee

University of Belgrade, Serbia
Serbian Chemical Society, Division of Medicinal Chemistry

UCB BioPharma SPRL, Belgium
Société Royale de Chimie (SRC), Medicinal Chemistry Division

University of Eastern Finland, Finland
Finnish Pharmaceutical Society

University of Salerno, Italy
Division of Medicinal Chemistry of the Italian Chemical Society (Divisione di Chimica Farmaceutica - Società Chimica Italiana, DCF-SCI)

Esteve Pharmaceuticals, Spain
EFMC Executive Committee

Consultant, United Kingdom
EFMC Executive Committee

Ghent University, Belgium
Medicinal and Bioorganic Chemistry Division of Royal Flemish Chemical Society (KVCV)

SCT & Mercachem-Syncom, The Netherlands
EFMC Executive Committee

Bayer AG, Germany
EFMC Executive Committee

The Hebrew University of Jerusalem, Israel
The Medicinal Chemistry Section of the Israel Chemical Society